About ATHX

Athersys is an biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem(R) cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. www.athersys.com.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ATHX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
URTY ProShares UltraPro Russell2000 105.8 M 1.05784E+08 2,016 2016 0.0% 2.50493E-05 8 K 8322
UWM ProShares Ultra Russell2000 184.1 M 1.84148E+08 2,016 2016 0.0% 3.35075E-05 14 K 13554
SBIO ALPS Medical Breakthroughs ETF 201.2 M 2.01211E+08 71 71 0.28% 0.0028 563 K 563391
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.7 B 1.87292E+10 3,568 3568 0.0% 0 82 K 82092
IWC iShares Microcap ETF 916.2 M 9.16246E+08 1,452 1452 0.05% 0.0005 454 K 454188
IWM iShares Russell 2000 ETF 44.9 B 4.48577E+10 2,006 2006 0.01% 0.0001 3.8 M 3849610
IWN iShares Russell 2000 Value ETF 9.2 B 9.22952E+09 1,371 1371 0.0% 0 84 K 84384
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28872E+09 1,239 1239 0.02% 0.0002 1.5 M 1483240
IWV iShares Russell 3000 ETF 9.7 B 9.71954E+09 2,931 2931 0.0% 0 38 K 38484

Wait, Before You Leave...